The Fetal Bovine Serum Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Fetal Bovine Serum Market:
https://www.thebusinessresearchcompany.com/report/fetal-bovine-serum-global-market-report
According to The Business Research Company’s Fetal Bovine Serum Global Market Report 2024, The fetal bovine serum market size has grown strongly in recent years. It will grow from $1095.25 billion in 2023 to $1176.47 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to expansion of biopharmaceutical industry, rise in cell-based therapies, quality and consistency requirements.
The fetal bovine serum market size is expected to see strong growth in the next few years. It will grow to $1644.06 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of cell therapies, emergence of advanced therapeutics, focus on animal-free alternatives, strategic supplier-customer relationships. Major trends in the forecast period include focus on quality and traceability, global collaboration and partnerships, strategic mergers and acquisitions, customized fetal bovine serum products, regulatory compliance and ethical sourcing.
The increase in demand for biopharmaceuticals is expected to drive the growth of the fetal bovine serum market in the forecast period. A biopharmaceutical is a medicinal product that is derived from biological sources such as animals, humans, and microorganisms using biotechnology. Fetal bovine serum (FBS) is the most widely used substitute for animal cell culture media. Pharmaceutical firms, diagnostic laboratories, and researchers rely heavily on FBS for much of their cell culture requirements in biologics research. In 2022, ProClinical Limited, a UK-based lifesciences service and consulting company, sales for the company’s pharmaceuticals and vaccines segments added up to US$36.15mn, an increase of 11% YOY. Therefore, the rising demand for biopharmaceuticals propels the growth of the fetal bovine serum market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=4109&type=smp
The fetal bovine serum market covered in this report is segmented –
1) By Product: Charcoal Stripped, Chromatographic, Dialyzed Fetal Bovine Serum, Exosome Depleted, Stem Cell, Other Products
2) By Application: Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human and Animal Vaccine Production, Diagnostics, Other Applications
3) By End-User: Research and Academic Institutes, Biotechnology and Pharmaceutical Industry, Other End-Users
Major companies operating in the fetal bovine serum industry are developing and focusing on innovative products such as USDA-approved fetal bovine serum to meet the needs of researchers and their budgets, offering consistent quality and value for basic research. USDA-approved fetal bovine serum is used to provide a high-quality serum that meets the rigorous safety standards set by the United States Department of Agriculture (USDA), and it is tested for the absence of specific diseases, making it a reliable option for various research and production applications. For instance, in August 2021, Thermo Fisher Scientific Inc., a US-based biotechnology company, introduced Gibco Fetal Bovine Serum. Thermo Fisher Scientific’s GibcoTM Fetal Bovine Serum is a qualified, heat-inactivated, USDA-approved product suitable for basic cell culture, specialty research, and specific assays. It is USDA-approved in North America and qualified in other regions, like Brazil. The product offers excellent value for research needs and budgets, with consistent quality and award-winning support from Gibco. It is ISO 13485-certified and processed in FDA-registered facilities. The product is suitable for cell culture with robust cell lines and has an endotoxin level of ≤ 20 EU/mL.
The fetal bovine serum market report table of contents includes:
1. Executive Summary
2. Fetal Bovine Serum Market Characteristics
3. Fetal Bovine Serum Market Trends And Strategies
4. Fetal Bovine Serum Market – Macro Economic Scenario
5. Global Fetal Bovine Serum Market Size and Growth
.
.
.
26. South America Fetal Bovine Serum Market
27. Brazil Fetal Bovine Serum Market
28. Middle East Fetal Bovine Serum Market
29. Africa Fetal Bovine Serum Market
30. Fetal Bovine Serum Market Competitive Landscape And Company Profiles
Top Major Players:
- Thermo Fisher Scientific Inc
- Merck KGaA
- GE Healthcare
- Corning Incorporated
- Cytiva
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
